Although alginate has been known to be a good wound dressing, it does not have antimicrobial properties, has low availability, and is expensive. To overcome these problems, the present study was conducted, where the extraction of this material from an available small factory Pseudomonas aeruginosa and the improvement of its wound healing property by its combination with herb extract, Alhagi maurorum, done. Nineteen P. aeruginosa strains were isolated and identified from burned skin, and the one isolated strain with the highest ability of alginate production was selected. A. maurorum aqueous extract was prepared, and the toxicity of each material was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide assay. A mixture of nontoxic doses of each substance was then prepared. Thirty-two Wistar rats were divided into four groups (n = 8). The control group and the rest three groups, which were treated by alginate, A. maurorum extract, and alginate-A. maurorum extract. Throughout the 21 days of treatment, the open wound sites were checked. Finally, the rats were sacrificed and the effect of each substance on their skin tissue was evaluated. The results showed that the high alginate production without any toxic effect was obtained from the P. aeruginosa strain K1. A. maurorum aqueous extract had dose-dependent toxicity. The aqueous solution of alginate-A. maurorum extract complex group showed the best wound healing activity in both macroscopic and microscopic examinations. Recent research has introduced a new type of wound dressing with high wound healing properties. This could decrease the time for re-epithelialization and increase wound contraction percentage.
inexpensive and its aqueous solution is nontoxic (Suggs et al., 1998) (Baysal, Aroguz, Adiguzel, & Baysal, 2013) . Although alginate has been known as a good wound dressing substance, it does not have antimicrobial properties. Hence, for better wound healing results, it is recommended to combine this type of dressing with anti-inflammatory, antimicrobial, or other useful agents, such as some kind of herb extracts.
Herb extracts from the first group (i.e., the traditional dressing) are used widely all over the world for different reasons in the wound area such as antibacterial, antifungal, antioxidant, and anti-inflammatory. (Kudi, Umoh, Eduvie, & Gefu, 1999) . The herb root, bark, leaf, and sometimes the whole herb is used to treat wounds (Boateng et al., 2008) .
Among the different medicinal herbs, it has been proven that A. maurorum has different types of metabolites such as glycosides, carbohydrates, flavonoids, resins, alkaloids, fatty acids, sterols, steroids, vitamins, and tannins that show antibacterial, antifungal, antipyretic, antiinflammatory, antioxidant, antiaging, antimutagenicity, and anticarcinogenic activities (Al-Snafi, 2015) . A. maurorum is native to Middle East, North Africa, South East Europe, and Asia (Al-Snafi, 2015) . The aqueous extract of this herb inhibits the release of proinflammatory mediators and exhibits anti-inflammatory properties (Okoli, Akah, & Ezugworie, 2006) .
Although the aqueous solution of alginate has been applied in the wound site previously, till date, no report is available on the histological alternations of the wound region after treating them with the altered alginate, which is combined with herb extract. Hence, this research was conducted to evaluate the wound healing efficiency of altered aqueous solution of alginate (a type of modern dressing) that was impregnated with A. maurorum aqueous extract (a type of traditional dressing) in the cutaneous wounds in rats (Baysal et al., 2013) .
| MATERIALS AND METHODS

| Isolation of bacteria
Sixty-four swabs of burned skin were obtained from the Imam Reza hospital burn unit, Mashhad, Iran. Each swab was placed in 9 ml of the Asparagine broth enrichment medium (Himedia, India) , and incubated at 37 C at 180 rpm for 72 hr (Al-Hinai et al., 2010) . Then, to produce colonies, a loop, full of each broth, was streaked onto Cetrimide agar (Himedia, India) and incubated at 37 C for 24 hr (Rashedi, Jamshidi, Assadi, & Bonakdarpour, 2005) . For alginate production, the obtained colonies, which were proven to be P. aeruginosa, were subcultured on a modified MacConkey agar (Himedia, India), which contained 3% glycerol and 0.25 M sodium chloride (Sigma Aldrich, USA), and incubated at 30 C for 1 week (Evans & Linker, 1973) .
| Bacterial identification tests 2.2.1 | Phenotyping test
Bacterial isolates were biochemically identified using the API 20 NE clinical diagnostic kit (Biomerieux, USA) that was suitable for the identification of nonfastidious, nonenteric Gram-negative rods (bioMerieux 20050).
| Genotyping test
All the bacterial strains that were identified as P. aeruginosa with the help of the phenotyping test were further analyzed using polymerase chain reaction (PCR). The DNA of the samples was extracted by the boiling method previously described by . The 63F (5 0 CAGGCCTAACAC ATGCAAGTC3 0 ) was used as the forward and 1389R (5 0 ACGG GCGGTGTGTACAAG3 0 ) as the reverse primers for the amplification of partial fragment of 16S rDNA (Pourali et al., 2013) . PCR was run in the presence of negative control, which contained ddH 2 O instead of the DNA sample. PCR, electrophoresis conditions, and purification of the products have been described earlier by Pourali et al. (2014) . The purified products were sequenced in one direction using the 63F primer, and the obtained data were compared using BLASTn program available in the National Centre for Biotechnology Information (NCBI) .
| Alginate extraction
To extract the alginate mucoidal colonies of P. aeruginosa on the modified MacConkey agar, they were washed using normal saline. For each 50 ml of the washed product, 2 ml of ethylenediaminetetraacetic acid (Sigma Aldrich, USA) (EDTA) (0.05 M) and 1 ml of NaCl (5 M) were added and the mixture was vortexed for 5 min. After centrifugation (14,000 rpm, 10 min), 50 ml of the obtained supernatant was precipitated using 150 ml of cold absolute ethanol (Sigma Aldrich, USA), 10% sodium acetate, and 1% glacial acetic acid (Sigma Aldrich, USA). The alginate pellet was then freeze dried (Anastassiou, Mintzas, Kounavis, & Dimitracopoulos, 1987) .
| Preparation of aqueous solution of alginate and assessment of its viscosity and concentration
To achieve the alginate aqueous solution, 0.3 g of alginate from each freeze-dried powder was dissolved in 100 ml of ddH 2 O. The viscosity of the resultant solutions was analyzed using a Brookfield Cone/Plate Viscometer, model DV2T at a shear rate of 12 1/s (Knutson & Jeanes, 1968) . The concentration of alginate from each freeze-dried powder was determined using the modified carbazole method (Knutson & Jeanes, 1968) .
Finally, based on the results obtained, a bacterium with the highest ability of alginate production was selected for further analysis.
| Preparation of A. maurorum aqueous extract
Fresh leaves and stems of A. maurorum were collected from the desert region around Damghan city, Iran. First, these herb parts were rinsed thoroughly with tap water and subsequently dried at room temperature for 1 week. The powder of these dried herb parts was made using an electric grinder.
Ten grams of the powder obtained from the herb was mixed with 200 ml of ddH 2 O and placed on the stirrer at 100 C for 30 min. The solution was then filtered using a filter paper (Sigma Aldrich, USA).
Thereafter, the filtrate was concentrated using a rotator evaporator and, finally, freeze dried (Le Son & Nguyen, 2013).
| Cytotoxicity assay
Before the cytotoxicity and wound healing assays, all the samples were sterilized using the tyndallization method. In brief, microtubes containing the samples were exposed to hot water vapor using a water bath for 30 min at the interval of 3 days. In between each treatment, the samples were incubated at 37 C overnight .
For the cytotoxicity assay, mouse fibroblast cell line (NIH-3 T3 D4), which was purchased from the Pasteur Institute of Iran, was used. The aqueous solution of alginate (0.3 g/100 ml) and the aqueous solution of A. maurorum extract in phosphate buffered saline (PBS) (10 mg/ml) were used separately for the 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT) assay.
The cells were cultured in a T 75 flask containing the working medium, which included Dulbecco's Modified Eagle's medium (DMEM, Sigma Aldrich, USA), 10% fetal bovine serum (Sigma Aldrich, USA), and 1% penicillin-streptomycin (Sigma Aldrich, USA). The flask was incubated in the presence of 5% CO 2 at 37 C for 24 hr. After achieving 80% confluent monolayer cell and its detachment using the trypsin-EDTA solution (Sigma Aldrich, USA), the cells were seeded in each of the 96 wells microtiter plate and again incubated in the condition mentioned above. After achieving 80% confluent monolayer cell in each well, the surfaces of the cells were washed by the aid of BPS and were exposed to an equal amount (100 μl) of two-fold concentration of the working medium. The wells in each row of the plate were used for one type of sample and were loaded by 100 μl of the tested sample. However, the concentration of the sample was reduced by half from the 1st well to the 11th one. The last well (i.e., the 12th well)
in each row was used as the control well, which contained only the cells in 200 μl of the working medium. The plate was incubated in the condition mentioned previously. Then, the medium was removed and the cells were washed using PBS. All the wells were loaded with 10 μl of MTT (Sigma Aldrich, USA) dye solution (5 mg/mL in PBS), and the plate was incubated for 4 hr. The dye was then removed, and 100 μl of dimethyl sulfoxide (DMSO, Sigma Aldrich, USA) was added to each well. Finally, the optical densities (ODs) of the wells were measured at 570 nm using enzyme-linked immunosorbent assay reader. This assay was repeated three times and the IC 50 of each sample was calculated based on the following formula (Pourali et al., 2017; Pourali, Razavian Zadeh, & Yahyaei, 2016) : were purchased from Pasteur Institute of Iran. In order for these test subjects to adapt, they were kept in different cages at 25 C in a cycle of 12 hr light and 12 hr darkness. Food and water were given ad libitum before and throughout the whole experiment procedure . For wound preparation, the rats were anesthetized using light ether (Sigma Aldrich, USA) and by the use of a sterilized circular blade one full-thickness wound (8 mm in diameter) on the dorsal body surface of each rat was made, after shaving and sanitizing their skins . For wound healing assay, the rats were divided into four random groups (n = 8). The control group was not treated. Out of the remaining three test groups, one group received aqueous solution of alginate, one received A. maurorum extract, and the last group received aqueous solution of alginate-A. maurorum extract complex. The wound beds were covered with 0.5 mg of above materials once daily for 21 days of the treatment.
| Macroscopic evaluations of the wounds
Every day, the wounds were macroscopically analyzed and the edges of the open wound area were measured. The wound contraction percentage was measured using the following formula: The wound con-
Wound zone size (mm) first day] × 100%.
The obtained results were analyzed using one-way analysis of variance (ANOVA) using SPSS software version 22, and the value of p < .05 was used as the cutoff for significance .
| Microscopic evaluations of the wounds
For microscopic analysis, two rats from each group were euthanized and skin samples (2 × 2 cm 2 ) from the wound area were obtained after 3, 7, 14, and 21 days of the wound induction. The skin samples were fixed using 10% buffered formalin (Sigma Aldrich, USA) and then embedded in paraffin. Using a microtome apparatus (HHQ-1508R
Rotary Microtome, Zhejiang, China), the samples were cut into sections of 5-mm thickness and stained using the hematoxylin and eosin (Sigma Aldrich, USA) (H&E) staining method. The levels of re-epithelialization, fibroplasia, inflammation, angiogenesis, and collagen bundles formation in each group were analyzed using the light microscope and compared with each other .
3 | RESULTS
| Isolation of bacteria
From the total of 64 swabs of skin samples, 19 colonies of P. aeruginosa were obtained with yellow-green to blue-green appearance on the Cetrimide agar; five of them had acceptable mucoidal colonies on the modified MacConkey agar.
| Bacterial identification tests 3.2.1 | Phenotyping test
All the five tested strains, with acceptable mucoidal colonies, were identified as the strain of P. aeruginosa using the API 20 NE clinical diagnostic kit and used for genotyping test.
| Genotyping test
The five bacterial strains, which were identified as P. aeruginosa by the phenotyping test, were further analyzed using PCR. After carrying out PCR and electrophoresis, the 1,299 bp obtained bands were visualized using the gel document system in the presence of 1 kb DNA ladder ( Figure 1 ).
Finally, the sequencing results were compared with the 16S Ribosomal RNA sequence database available at NCBI. The results are shown in Table 1 .
| Alginate extraction
The alginate was extracted successfully from the five selected mucoidal colonies of P. aeruginosa. The obtained extract and the results from each step are shown in Figure 2 .
| Preparation of aqueous solution of alginate and assessment of its viscosity and concentration
For the viscosity and concentration evaluations, aqueous solutions from five bacterial alginate samples were prepared and the results obtained were compared with each other. Table 2 shows these results.
| Cytotoxicity assay
The results from the MTT assay demonstrated that the aqueous solution of alginate did not show cytotoxic effects in the cell culture.
A. maurorum extract had dose-dependent toxic effects in the cell culture. Hence, based on the obtained ODs, IC 50 for the aqueous solution of alginate was not achieved (i.e., the aqueous solution of alginate was safe). The IC 50 of A. maurorum extract calculated in the second well and was equal to 2.5 mg/ml of A. maurorum extract in PBS. The 1st well contains the highest concentration and the 11th well contains the lowest concentration of each sample. The 12th well was the control well, which had no sample addition. Figure 3 represents the cell viability percentages that were calculated from the obtained ODs.
Finally, 10 ml of the aqueous solution of alginate was mixed with 25 mg of A. maurorum extract and the resultant complex was used for in vivo studies.
| Wound healing assay 3.3.1 | Macroscopic evaluations of the wounds
The results obtained were analyzed using one-way ANOVA and it was observed that there were significant differences among all the four tested groups on the 3rd, 7th, 14th, and 21st days of treatment. As can be seen in Table 1 and Figure 1 , on Day 3, the maximum wound contraction percentage was found in the group that had received the , maximum wound contraction percentage was seen in the group that was treated by aqueous solution of alginate-A. maurorum extract complex and the minimum one was seen in the control group (Table 3 and Figure 4 ).
| Microscopic evaluations of the wounds
Histological variations of cutaneous wounds in the rat groups following their treatment with aqueous solution of alginate, A. maurorum extract, and aqueous solution of alginate-A. maurorum extract complex in contrast to the control group were analyzed. In the control group, on Day 3, the level of fibroplasia was acceptable, but the formation of collagen bundles was low. New blood vessels could be seen and the infiltration of inflammatory cells into the wound area was present. On Day 7, the level of the fibroplasia, collagen bundle formation, and infiltration of inflammatory cells were similar to that of Day 3. The diameter of the collagen bundles was about 1 μm. However, the level of new blood vessels was lower. On Day 14, collagen bundles with acceptable thickness were not formed. The skin contents, such as hair follicles, appeared. On Day 21, the levels of collagen bundles were in the acceptable range with the thickness about 6 μm in diameter, whereas the level of inflammatory cells was lower. In the group that received A. maurorum extract daily, on Day 7, the diameter of the collagen bundles was about 5 μm and on Day 14, the skin contents appeared. On that day, the level of inflammatory cells in the wound area was low and the collagen bundles with acceptable thickness were not formed. On Day 21, the collagen bundles with acceptable thickness (about 8 μm in diameter) could be seen, and the epithelial tissue and skin contents were completely formed. In the group that was received aqueous solution of alginate daily, on Day 7, the epithelial tissue with low thickness was observed and skin contents were formed. The levels of fibroplasia and formation of collagen bundles (with the thickness about 4 μm in diameter) were acceptable, but the level of inflammatory cells in the wound area was high. On Day 14, the thickness of the epithelial tissue and collagen bundles were acceptable. Finally, on Day 21, very thick collagen bundles (about 7 μm in diameter) could be seen. In the group that was treated by aqueous solution of alginate-A. maurorum extract complex, on Day 7, fibroplasia with hyperemia and infiltration of inflammatory cells were observed. The diameter of the collagen bundles was about 7 μm.
On Day 14, the complete formation of epithelial tissue, along with stratum corneum, was present. The thickness of the collagen bundles was acceptable, natural, and seen in the diameter around. Finally, on
Day 21, the skin contents were formed and the diameter of the collagen bundles was about 13 μm. Figure 5 represents histological sections of the cutaneous wounds of all four tested groups, on four different days of the examination. The cell viability percentages results obtained from the aqueous solution of A. maurorum extract. The 1st well contains the highest concentration (i.e., 5 mg/ml) and the 11th well contains the lowest concentration (i.e., 0.004 mg/ml) of the sample. The 12th well was the control well, which had no sample addition. The IC 50 of A. maurorum extract calculated in the second well and was equal to 2.5 mg/ml of A. maurorum extract in PBS 4 | DISCUSSION It was reported that to achieve an acceptable wound healing without production of scars, avoiding of dehydration of the wound environment is very important. In the harmed skin, dehydration of the wound area is 20 times greater than the healthy one (Kamoun, Kenawy, & Chen, 2017) . Hence, recently, the use of different types of wound dressings with high ability of water maintenance is taken in to account.
Also, if the type of dressing being used protects the wound area from pathogens, stimulates the growth factors, reduces necrosis, reduces pain, reduces the time taken for completing the epithelialization, is easily available and easily changeable, easy to use, and biocompatible, then it will be desirable for wound healing applications (Kamoun et al., 2017) .
There are two types of wound dressings: traditional and modern.
Each of these has its own advantages and disadvantages. Some of them are natural and some are produced artificially (Queen et al., 2004) . Among the natural wound dressings, the biologically produced one, such as the bacterial cellulose membrane (Pourali, Razavianzadeh, Khojasteh, & Yahyaei, 2018), bacterial hyaluronic acid, and bacterial alginate, are among the most attractive ones, because their production FIGURE 4 Macroscopic changes of the wounds in the four different groups, tested on four different days of the experiment is simple and the produced polymer is pure (Kamoun et al., 2017) .
These materials are in the form of gels and hydrogels with water retaining properties. In our previous studies, the successful extraction of the bacterial cellulose membrane (Pourali et al., 2014) and bacterial hyaluronic acid was achieved, which have applications in the medical field. The present study was conducted on the production of alginate and the analysis of its wound healing properties alone and in combination with a type of medicinal herb extract. Therefore, a kind of wound dressing, which was made from both traditional and modern dressings, was introduced and applied in vivo.
The P. aeruginosa is a pathogenic bacterium that is usually isolated from immune compromised patients who have suffered from chronic illnesses or those who have cystic fibrosis. Researche on this dangerous bacterium usually are on its treatment ways and its drug resistant mechanisms. Some strains of this bacterium, which have a mucoidal appearance, can produce alginate (Kamoun et al., 2017) , which is a linear copolymer. The tendency of the bacterium to produce alginate is as a result of its pathogenesis. By the production of this polymer, it can escape from phagocytosis, modulates the synthesis of proinflammatory cytokines, and cause the disease (Kashef et al., 2006) . Unlike the undesirable appearance of this bacterium in the medical field, P. aeruginosa can be used as an available factory that produces a kind of modern dressing named alginate. This substance is a water-soluble polysaccharide, is biodegradable, and a biocompatible polymer that is proven to be nontoxic. Its good gelling property, along with high ability to retain water, has made it a good candidate for use in the medical field, such as drug delivery or as a wound dressing agent (Mazur, Buchner, Bonn, & Hunger, 2014) .
It has been reported that alginate is suitable for surgical wounds and skin burns. Although this natural polymer has some advantages, such as good stability in the environment, nontoxic effects, ease of removal using normal saline solution, high water retaining ability, high FIGURE 5 Microscopic changes of the wounds in the four different groups, tested on four different days of the experiment (H&E ×400). Scale bars = 20 μm mechanical stability, and is an acceptable microorganism barrier, it has some disadvantages as well, such as its high cost, unavailability for every patient, and absence of antibacterial properties (Kamoun et al., 2017) .
To overcome these disadvantages, using P. aeruginosa as an available small factory and combining its extracted alginate with a natural material used for wound healing, such as a kind of herb extract, are suggested in the present study.
A. maurorum is a type of medicinal herb that is used as a type of traditional wound dressing agent in some parts of the world, such as Asia. It has been proven that it has antimicrobial, antiinflammatory, antioxidant, antiaging, antimutagenicity, and anticarcinogenic characteristics (Ahmad et al., 2015) . In this research, the leaves and stems of this medicinal herb are used as antimicrobial agents in combination with the bacterial aqueous solution of alginate. This mixture is then used to examine whether the wound healing activity of the gel was improved with the addition of A. maurorum extract or not.
In the first step of the present study, the mucoidal colonies of P. aeruginosa were isolated from the patient's burned skin. It has been reported that the bacterial alginate secretion can be enhanced if the MacConkey agar is enriched with 3% glycerol (vol/vol) (Mai, Seow, Pier, McCormack, & Thong, 1993) . Also, based on the recommendation by McAvoy et al. (1989) , an incubation period of 1 week was used for better alginate production as the bacterium produces mucoidal colonies slowly (i.e., the production rate of alginate is slow).
In the next step, five strains with the highest ability of alginate production (i.e., the colonies with the best mucoidal texture) were achieved and identified with the help of phenotyping and genotyping methods and confirmed that they were strains of P. aeruginosa. The extraction of the alginate was carried out, and the viscosity and concentration of the alginate from each strain were evaluated. The results
showed that a strain with 95% similarity with "P. aeruginosa strain K1"
had the best capacity of alginate production. This produced alginate was used for in vitro and in vivo assays. As shown in the results section, the viscosity and concentration of the aqueous solution of the produced alginate were around 110 cP and 0.5 g/l respectively, which is in contrast to the previous studies by Leitão and Sá-Correia. The latter showed that the high mucoidal P. aeruginosa strain in different environmental conditions could produce alginate with high viscosity and concentration, around 280 cP and 1.2 g/l, respectively (Leitão & Sá-Correia, 1997) . The ability of to produce alginate by the isolated strain in the recent study, without any changes in the environmental factors, was acceptable.
Parallel to these experiments, the aqueous extract of the herb was prepared and the derived extract was dried and weighed.
A. maurorum extract and the alginate aqueous solution were used for the MTT assay. Although some of the previous studies directly used the herb extracts (Nagar et al., 2016) or polymers (Roh et al., 2006) for in vivo assays, in this research, the nontoxic concentration of each material was determined first. Then, the substance was used for in vivo analyses, in its calculated nontoxic dose.
The tested substances were first sterilized using the tyndallization method as microbial contaminations can interfere with the results of the MTT test. The tyndallization method is easy, safe, and free of adverse effects on the tested materials .
For MTT assay, the type of cells being used is very important. In this research, the noncancerous fibroblast cell line was used. If the cancerous cell line is used, the results may differ from the ones obtained in the present study, because the behavior of this type of cell is different from the normal cells. For example, they grow quickly and some of their types are resistant to chemotropic agents. The fibroblast cell type was used as it is present in all the body tissues. Moreover, the fibroblast cell plays a critical role in collagen bundles and other cellular matrix synthesis. Hence, it is important to know the amount of toxicity caused by each material on the fibroblast cell and only use those doses which do not impose any toxic effects on this type of cell (Wang et al., 2015) . The MTT assay results showed that the aqueous solution of alginate did not impose toxic effects on the tested cells, whereas the plant aqueous extract had dose-dependent toxicity. The nontoxic dose of the latter extract was determined. Using the nontoxic dose of each extract for wound healing studies, the maximum synthesis of collagen bundles and wound contraction percentage, and minimum time for completing the epithelial tissue, were achieved during these examinations.
Periodic checking of the wound sites for the four tested rat groups indicated that the application of the aqueous solution of alginate, the aqueous extract of A. maurorum, and the combination of both, could all improve the rate of wound contraction percentage.
Though these data differ between the groups, there were significant differences between the three tested groups as compared to the control one, which did not receive any treatment.
Studies have shown that the aqueous solution of alginate and the aqueous extract of A. maurorum both had acceptable wound healing efficiencies. This property of aqueous solution of alginate was because of its ability to retain a moist environment in the wound and serve as a physical barrier that prevents the entry of bacteria into the wound area. A moist environment resulted in an optimal condition for cell proliferation, which is a critical condition to rapidly achieve the healing of wounds (Cardinal et al., 2009) . It has been shown that the acidic pH in the wound site had the best ability in the healing of the wounds; hence, some research tried to use acidic agents such as acetic and citric acids (Schneider et al., 2007) . Therefore, in the recent study, the wound healing ability of the alginic acid is as a result of its acidic pH.
Also, it has been reported that the aqueous extract of
A. maurorum has anti-inflammatory properties, which can aid the healing of the wound site. It has been previously shown that A. maurorum aqueous extract has antimicrobial activities and, therefore, the wound healing activity of A. maurorum extract might be caused by the eradication of pathogenic microorganisms that are present in the wound area. The results showed that a combination of these two substances (i.e., an aqueous solution of alginate-A. maurorum extract complex) had excellent wound healing characteristics, which had not previously been reported. Overall, macroscopic evaluations of the wounds showed that the aqueous solution of alginate in the first few days and the aqueous solution of alginate-A. maurorum extract complex in the last few days of the treatment had maximum effect on the recovery of wounds. Although the wound contraction percentage is an important factor for the evaluation of the wound healing properties of each tested solution, microscopic examination of the wounds on different days of the experiment must also be taken into account. Histological results of the wounds on different days of the experiment (i.e., Days 3, 7, 14, and 21) revealed that overall the groups which were treated by the aqueous solution of alginate, A. maurorum extract, and aqueous solution of alginate-A. maurorum extract complex had better wound healing efficiency, in contrast to the control group. However, there were some differences between the three above mentioned test groups. Analysis revealed that among these three groups, the group which received aqueous solution of alginate-A. maurorum extract complex was the best one.
For example, on Day 14, in contrast to the other tested groups, complete re-epithelialization, along with the presence of stratum corneum, was observed in this group. Also, a high content of the thick collagen bundles was seen in this group, which was in contrast to the group that received a daily dose of aqueous solution of alginate. In the control and A. maurorum extract groups, the thickness of the collagen bundles was absent.
In the present study, the alginate was extracted from a pathogenic bacterium, which produces it for decreasing the proinflammatory cytokines. Therefore, the extracted alginate showed low adverse tissue reaction and low toxicity. In future, it is recommended to examine this type of dressing in diabetic ulcers of the experimental animals.
| CONCLUSION
In conclusion, this research has introduced a new, inexpensive, available, and nontoxic type of dressing, which is produced by the combination of modern and traditional dressings that showed superior wound healing properties. The wound dressing agent produced had low toxicity and excellent histocompatibility characteristics, which decreased the time for re-epithelialization and increased the wound contraction percentage. This new dressing is a good candidate for the treatment of ulcers in different patient populations, such as patients who suffer from burns or diabetes.
